Q: What is Ginsin, Goldaru about?
A: Ginsin, Goldaru is a 2024 film campaign created by 2milimeters for the Iranian pharmaceutical brand Goldaru, directed by Javad Samiei. The narrative centers on children who, seeking more playtime, attempt to make their parents sleep by adding a sleep-inducing medicine to cakes. However, they mistakenly use Goldaru’s ginseng medicine instead, which energizes the adults rather than putting them to sleep. The campaign uses this family scenario to highlight the invigorating effects of Goldaru’s ginseng product, blending humor and warmth to connect with its audience in the healthcare market.
Q: What creative device does Ginsin, Goldaru use?
A: Ginsin, Goldaru employs the Benefit Causes Story format, classified by Clapboard’s 12-format taxonomy as FORMAT#6. This creative device builds a narrative where the product’s benefit directly causes the story’s central action and twist. In this case, the energizing effect of Goldaru’s ginseng medicine leads to an unexpected outcome that drives the plot, subverting expectations and showcasing the product’s value through storytelling rather than explicit claims.
Q: What is the campaign proposition for Ginsin, Goldaru?
A: The campaign positions Goldaru as a brand that delivers unexpected vitality and cheerfulness through its pharmaceutical products, specifically emphasizing the energizing benefits of ginseng. Targeting families and caregivers in Iran, it uses a relatable family dynamic and humor to communicate natural, mood-enhancing health solutions. This approach highlights Goldaru’s commitment to accessible, family-friendly wellness that improves everyday life without relying on clinical or medical claims.
Q: How does Ginsin, Goldaru rank in Clapboard's archive?
A: Ginsin, Goldaru holds a Clapboard Campaign Score of 63/100. This score reflects the campaign’s creative ambition, execution quality, and cultural relevance as assessed by Clapboard’s global ad archive.
Q: Who are the competitors in Goldaru's category?
A: Goldaru competes with several key pharmaceutical companies in Iran, including Darou Pakhsh, which leads with a broad portfolio of high-quality medicines and strong research and development; Sobhan Darou, known for specialized products in cardiovascular and metabolic diseases; Exir Pharmaceutical Company, which focuses on affordable prescription medicines with expanding export markets; Tolid Darou, distinguished by its blend of traditional herbal knowledge and modern pharmaceutical standards; and Osveh Pharmaceutical Company, which emphasizes cost-effective generic medicines and sustainability with international quality certifications.